He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the molecule lenacapavir, offers a more effective and less invasive prevention method,

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.